Current drugs for sedation of critically III patients

Seminars in Anesthesia

Volumn 20, Issue 2, 2001, Pages 85-94

  Prielipp, Richard C ^a,b   Young, Christopher C ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; ETOMIDATE; NEUROLEPTIC AGENT; PROPOFOL; SEDATIVE AGENT;

AMNESIA; CRITICAL ILLNESS; DRUG USE; HUMAN; INTENSIVE CARE; PRIORITY JOURNAL; REVIEW; SEDATION; STRESS; TREATMENT INDICATION;

EID: 0034952533     PISSN: 02770326     EISSN: None     Source Type: Journal    
DOI: 10.1053/sane.2001.23381     Document Type: Article

References (29)

1. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation
2. The use of continuous IV sedation is associated with prolongation of mechanical ventilation
3. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: A randomised trial
4. Unplanned extubation. Clinical predictors for reintubation
5. Modulating effects of propofol on metabolic and cardiopulmonary responses to stressful intensive care unit procedures
6. Neurological sequalae in children after prolonged propofol infusion
7. A method to produce sedation in critically ill patients
8. Controlled sedation with alphaxalone/alphadolone
9. Prospective evaluation of the sedation-agitation scale for adult critically ill patients
10. Assessing sedation during intensive care unit mechanical ventilation with the bispectral index and the sedation-agitation scale
11. Propylene glycol toxicity related to high-dose lorazepam infusion: Case report and discussion
12. Effect of diltiazem on midazolam and alfentanil disposition in patients undergoing coronary artery bypass grafting
13. Reversible neurological abnormalities associated with prolonged intravenous midazolam and fentanyl administration
14. Propofol: An update on its clinical use
15. Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients
16. Sedation in the intensive care unit: A systematic review
17. Sedation in the intensive care unit
18. Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients
19. Comparison of the effects of 24-hour propofol or fentanyl infusions on intracranial pressure
20. Torsades de pointes associated with intravenous haloperidol in critically ill patients
21. Influence of sedation on mortality in critically ill multiple trauma patients
22. Pharmacoeconomic issues of sedation, analgesia, and neuromuscular blockade in critical care
23. Dexmedetomidine
24. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate
25. The effects of increasing plasma concentrations of dexmedetomidine in human
26. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery
27. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit
28. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions
29. Effects of dexmedetomidine a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: In vivo and in vitro studies